2-Phenyl-1,3-oxazole-4-carboxylic acid, 97.0%, 250mg

Dipropylene glycol monobutyl ether, min 98%, for synthesis, 1L, plastic packaging.

6-Bromo-2-phenyl-1H-imidazo[4,5-b]pyridine, 95.0%, 1g

(R)-(-)-1-METHYL-3-PHENYLPROPYLAMINE, 95%, 500mg

6-Bromo-8-methylquinoline, 95.0%, 1g

2-(3,3-Difluoropyrrolidin-1-yl)ethan-1-ol, 98%, 100mg

(2S,3S)-3-Methylpent-4-en-2-ol, 97%, 250mg

Cyclohexyl cyclohexanecarboxylate, 95.0%, 1g

L-Azetidine-2-carboxylic acid, 98.0%, 250mg

4-benzylsulfonylpiperidine hydrochloride, 95.0%, 500mg

Ru(OAc)2[(S)-xylbinap]200mg

(R)-3-((tert-Butoxycarbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid, 95.0%, 1g

3,4-Dihydro-2H-pyran-6-carboxylic acid, 95.0%, 25g